About
Aegerion Pharmaceuticals, Inc. develops and commercializes therapies for rare and ultra-rare lipid disorders, focusing on conditions such as homozygous familial hypercholesterolemia (HoFH).
Explore Aegerion Pharmaceuticals, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.